跳至主要内容
临床试验/NCT03434912
NCT03434912Unknown不适用

Identification and Evaluation of the Potential Biomarkers on Circulating Tumor Cells and Tumor Related Rare Cells in Cancer Patients Undergoing Immunotherapy

MiCareo Taiwan Co., Ltd.1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2017年5月24日最近更新:
适应症

试验速览

阶段
不适用
入组人数
80
试验地点
1
主要终点
Circulating tumor cell

研究概览

简要总结

The primary objective of this study is designed to evaluate the enumeration of circulating tumor cells and identify the potential biomarkers associated with clinical outcome. The secondary objective is to explore whether the changes of tumor related rare cells associates clinical outcome.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Evidence of a personally signed and dated informed consent document indicating that the subject (or a legal representative) has been informed of all pertinent aspects of the study.
  • Over 20 years of age.
  • Cancer patients on immune checkpoint inhibitors.

排除标准

  • Subjects who have other cancer history
  • Pregnant females
  • Subjects with active, known or suspected autoimmune disease.
  • Known history of human immunodeficiency virus (HIV)

结局指标

主要结局

Circulating tumor cell

时间窗: 1 years

Isolation and analysis of circulating tumor cells before and after immunotherapy

次要结局

  • tumor related rare cell(1 years)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Identification and Evaluation of Circulating Tumor... | 临床试验